Wednesday, July 28th | 19 Av 5781

Subscribe
October 31, 2019 9:37 am
0

Report: Mnuchin Proposes FDA Branch in Israel, Meets With Health Officials

avatar by JNS.org

US Secretary of the Treasury Steven Mnuchin. Photo: Ricky Harris / The White House.

JNS.org – US Treasury Secretary Steven Mnuchin met on Tuesday with Israeli health officials to discuss opening an Israeli branch of the US Food and Drug Administration (FDA), a Treasury spokesperson told JNS.

Calcalist first reported the meeting.

The meeting, which included Marius Nacht, co-founder of life sciences and healthcare venture capital fund aMoon, as well as senior executives from Israeli health-maintenance organization Clalit and Sheba Medical Center, was held at the home of US Ambassador to Israel David Friedman in Herzliya.

The FDA has few branches outside the United States, including those in China, and several European and Latin American nations.

Related coverage

July 27, 2021 5:20 pm

IDF Says Human Rights Watch Report ‘Recycled Disproven Claims’ to Allege Israeli War Crimes During Hamas Conflict

The Israeli military rebuffed a Human Rights Watch report published Tuesday that accused the IDF of carrying out attacks amounting...

“At first glance, Israel is too small to meet the FDA criteria for a local branch, but the matter is being considered due to the country’s unusually large concentration of biotech and medtech companies,” reported Calcalist, citing a source familiar with the matter. “While it will not replace the need to apply for FDA clearance in the US, it could shorten the application process for Israeli companies.”

Estimates are that such a branch could be established in Israel in the near future, the person said.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.